Unresectable Metatstatic Cutaneous Melanoma
1 clinical trials · Condition
◉ Watch Unresectable Metatstatic Cutaneous Melanoma
| Record | Firm | Date |
|---|---|---|
| Use of 852A in Metastatic Cutaneous Melanoma. (NCT00189332) | Pfizer | 2005-02-01 |
Track Unresectable Metatstatic Cutaneous Melanoma automatically
Every clearance here is in the API, with alerts when new ones post.